Pilot Research Study on the Provision of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol With Female Cancer Patients

Jarero, Ignacio; Artigas, Lucina; Uribe, Susana; García, Laura Evelyn; Cavazos, María Alicia; Givaudan, Martha

doi:10.1891/1933-3196.9.2.98

Cited by 35 publications

(48 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also, sometimes more than 10 memories per patient were targeted during the intensive treatment. Important differences relative to earlier EMDR studies (Grey, 2011;Jarero et al, 2015;Lobenstine & Courtney, 2013;Proudlock & Hutchins, 2016;E. Shapiro & Laub, 2015;Wesson & Gould, 2009) were that the patients stayed at the institution twice, for 4 consecutive days in a row, and were offered an intensive sports program as well as psychoeducation.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Intensive EMDR to Treat Patients With Complex Posttraumatic Stress Disorder: A Case Series

Bongaerts¹,

Minnen

Jongh

2017

J EMDR Prac Res

View full text Add to dashboard Cite

There is mounting support for the notion that also, individuals with severe, or "complex," forms of PTSD respond positively to TFTs and that neither trauma history, comorbidity, nor severe dissociative symptoms negatively affect clients' response to TFTs Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002;Hagenaars, van Minnen, & Hoogduin, 2010;Jerud, Pruitt, Zoellner, & Feeny, 2016;Olatunji, Cisler, & Tolin, 2010;van den Berg et al., 2015;van Minnen, Arntz, & Keijsers, 2002;van Minnen, Harned, Zoellner, & Mills, 2012; There is mounting evidence suggesting that by increasing the frequency of treatment sessions, posttraumatic stress disorder (PTSD) treatment outcomes significantly improve. As part of an ongoing research project, this study examined the safety and effectiveness of intensive eye movement desensitization and reprocessing (EMDR) therapy in a group of seven (four female) patients suffering from complex PTSD and multiple comorbidities resulting from childhood sexual abuse, physical abuse, and/or work and combatrelated trauma. Treatment was not preceded by a preparation phase and consisted of 2 3 4 consecutive days of EMDR therapy administered in morning and afternoon sessions of 90 minutes each, interspersed with intensive physical activity and psychoeducation. Outcome measures were the Clinician-Administered PTSD Scale (CAPS) and the PTSD Symptom Scale Self-report questionnaire (PSS-SR). During treatment, neither personal adverse events nor dropout occurred. CAPS scores decreased significantly from pre-to posttreatment, and four of the seven patients lost their PTSD diagnosis as established with the CAPS. The results were maintained at 3-month follow-up. Effect sizes (Cohen's d) on the CAPS and PSS-SR were large: 3.2, 1.7 (prepost) and 2.3, 2.1 (prefollow-up), respectively. The results of this case series suggest that an intensive program using EMDR therapy is a potentially safe and effective treatment alternative for complex PTSD. The application of massed, consecutive days of treatments using EMDR therapy for patients suffering from PTSD, particularly those with multiple comorbidities, merits more clinical and research attention.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Shapiro & Laub, 2015;Wesson & Gould, 2009), the treatment consisted of a very limited number of sessions (Grey, 2011;Proudlock & Hutchins, 2016;E. Shapiro & Laub, 2015), and/or treatment was combined with other psychotherapeutic treatment ingredients ( Jarero et al, 2015;Lobenstine & Courtney, 2013).…”

Section: Intensive Emdr Therapymentioning

confidence: 99%

Intensive EMDR to Treat Patients With Complex Posttraumatic Stress Disorder: A Case Series

Bongaerts¹,

Minnen

Jongh

2017

J EMDR Prac Res

View full text Add to dashboard Cite

show abstract

“…DuHamel and colleagues 71 found that a ten-session, telephone-based CBT intervention designed to address cancer-related PTSD was more effective than was an assessment-only control condition in reduction of intrusive ideation (p<0·05), avoidance (p<0·001), and general distress and depression (p<0·05) in haemapoietic stem-cell transplant survivors. Eye movement desensitisation and reprocessing (EMDR) 72 interventions have also shown promise in reduction of cancer-related PTSD symptoms (p<0·001), 73 although the mechanisms of EMDR are unclear. 74 Supportive expressive group therapy 59 has reduced re-experiencing and avoidance symptoms in women with metastatic breast cancer (effect size 0·25, p=0·03).…”

Section: Implications For Practicementioning

confidence: 99%

Post-traumatic stress disorder and cancer

Cordova

Riba

Spiegel

2017

The Lancet Psychiatry

332

290

View full text Add to dashboard Cite

Being diagnosed with and treated for cancer is highly stressful and potentially traumatic. An extensive literature has evaluated the prevalence, predictors, and correlates of cancer-related post-traumatic stress disorder (PTSD) symptoms and diagnoses. In this qualitative review of cancer-related PTSD literature, we highlight conceptual, methodological, and diagnostic issues, and identify clinical implications and areas for future research. Cancer-related PTSD has been documented in a minority of patients with cancer and their family members, is positively associated with other indices of distress and reduced quality of life, and has several correlates and risk factors (eg, prior trauma history, pre-existing psychiatric conditions, poor social support). The literature on treatment of cancer-related PTSD is sparse. Existing literature on cancer-related PTSD has used DSM-IV-TR diagnostic criteria; the revised DSM-5 PTSD criteria have important implications for the assessment of cancer-related distress. Application of PTSD diagnosis to patients with cancer has been critiqued on conceptual and methodological grounds, and important differential diagnosis considerations should be taken into account. Psychosocial assessment of patients with cancer should include careful evaluation of pre-cancer diagnosis trauma and psychiatric history, and diagnostic interviewing should consider concurrent conditions (eg, adjustment disorder). Treatment of cancer-related PTSD should be approached with caution and be informed by existing evidence-based approaches for traumatic stress.

show abstract

“…Jarero et al, conducted a pilot study to evaluate the effectiveness of EMDR-Integrative Group Treatment Protocol Adapted for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in reducing cancer-related posttraumatic stress disorder (PTSD) for adult women [13]. EMDR intensive therapy was administered for three consecutive days, twice daily, to 24 adult women diagnosed with different types of cancer (cervical, breast, colon, bladder, and skin) who had PTSD symptoms related to their diagnosis and treatment.…”

Section: Emdr Therapy Provided In Group Formatmentioning

confidence: 99%

PTSD, Immunoglobulins, and Cortisol Changes after the Provision of the EMDR - PRECI to Females Patients with Cancer-Related PTSD Diagnosis

Estrada¹,

Angulo²,

Navarro³

et al. 2019

AJAP

Self Cite

View full text Add to dashboard Cite

EMDR therapy administered to patients with cancer has proven to be effective in the reduction of posttraumatic stress disorder (PTSD) symptoms and PTSD diagnosis remission. The main objective of this study was to measure the PTSD scores and diagnosis changes before and after the provision of the EMDR-Protocol for Recent Critical Incidents and Ongoing Traumatic Stress (EMDR-PRECI) to female patients with cancer-related PTSD diagnosis. A secondary objective was to observe the immunoglobulins and the cortisol changes pre and post-treatment. Seven female patients with different types of cancer (5 breast, 1 colon, and 1 lymphatic cancer), different cancer treatments (radiation, chemotherapy, radiation, and chemotherapy), and PTSD diagnosis related to their diagnosis and cancer treatment met the inclusion criteria. Participants' age ranged from 40 to 57 years old (M = 52.28 years old). For PTSD diagnosis and total scores, we used the Global Assessment of Posttraumatic Stress Questionnaire validated for the Mexican population. Biomarkers (cortisol and immunoglobulins) were measured before and after EMDR treatment. For the neuroendocrine measure, we used the cortisol levels in the participant's blood. For the immunological measure, we used the Nephelometry technique. We measured the changes in the following types of antibodies (immunoglobulins): a) Immunoglobulin A (IgA), b) Immunoglobulin G (IgG), and c) Immunoglobulin M (IgM). EMDR-PRECI was provided by three licensed EMDR clinicians formally trained in the protocol administration. Each EMDR-PRECI session lasted 50-60 minutes. The minimum number of sessions was three and the maximum ten with an average of five. Treatment focused only on the distressing memories related to diagnosis and cancer treatment. No adverse effects were reported during treatment or at six months post-treatment assessment. Results showed a full PTSD diagnosis remission in all participants with significant differences for PTSD scores, t (6) = 2.44, p < .05. These results are in concordance with Carletto et al., study in which all patients treated with EMDR no longer met criteria for PTSD [12]. No significant differences were found for immunoglobulins or cortisol. We believe that the administration of the EMDR-PRECI could be an efficient and effective component of a psychosocial approach to reduce or eliminate cancer-related PTSD symptoms and diagnosis.

show abstract

Pilot Research Study on the Provision of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol With Female Cancer Patients

Cited by 35 publications

References 22 publications

Intensive EMDR to Treat Patients With Complex Posttraumatic Stress Disorder: A Case Series

Intensive EMDR to Treat Patients With Complex Posttraumatic Stress Disorder: A Case Series

Post-traumatic stress disorder and cancer

PTSD, Immunoglobulins, and Cortisol Changes after the Provision of the EMDR - PRECI to Females Patients with Cancer-Related PTSD Diagnosis

Contact Info

Product

Resources

About